1. Low incidence of anti‐drug antibodies in patients with type 2 diabetes treated with once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide. Issue 5 (4th March 2016) Authors: Milicevic, Z.; Anglin, G.; Harper, K.; Konrad, R. J.; Skrivanek, Z.; Glaesner, W.; Karanikas, C. A.; Mace, K. Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 5(2016) Page Start: 533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗